• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number ERES40018X
Device Problems Inadequacy of Device Shape and/or Size (1583); Malposition of Device (2616)
Patient Problems Stenosis (2263); Patient Problem/Medical Problem (2688)
Event Date 02/01/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
A patient was admitted for progressive chest pain.Four years ago, the patient had surgical aortic valve replacement (savr), and preoperative multislice computed tomography (msct) showed no coronary stenosis.A year after savr, the patient presented with chest pain, and coronary angiogram revealed an isolated ostial left main coronary artery (lmca) stenosis.A 4.0 mm × 18.0 mm medtronic stent was implanted without a high-pressure postdilation.The patient was discharged on aspirin, ticagrelor (replaced with clopidogrel after 3 months), and statins.Unfortunately, the stent was found to protrude into the aorta by approximately 10 mm by msct at 4-month follow-up.During this admission, the patient underwent nonselective coronary angiography due to the previous excessively protruding stent and showed in-stent restenosis (isr) at ostial lmca.It was almost impossible to place a guidewire through ostium to center lumen of previous stent in this context.A non-medtronic guidewire via the nonengaged jl4.0 (6f) medtronic guiding catheter was attempted to advance into distal left anterior descending through side strut of previous stent, which was confirmed by intravascular ultrasound (ivus).A 2.0 mm × 15.0 mm sprinter semicompliant balloon was positioned to the side strut and inflated at 8 atm with caution incase of strut deformation and then deposited to the isr and inflate at 10¿14 atm.Optical coherence tomography (oct) was performed and found focal and concentric fibrous intimal hyperplasia with stent malapposition at ostial lmca.A 4.0 mm × 18.0 mm non-medtronic stent was deployed following by a 4.0 mm × 12.0 mm sprinter noncompliant balloon inflate at 16 atm.Subsequent oct confirmed good stent expansion without strut malapposition, while ivus showed the proximal segment of the new stent protruded approximately 7 mm into the aorta.Thus, two stents exaggeratedly protruding from the lmca into the aorta were observed by postoperative msct.The patient was asymptomatic on aspirin and ticagrelor, and both stents remained at good patency at 1-year msct follow-up.
 
Manufacturer Narrative
It was reported that the medtronic stent was placed improperly, and the stent was selected too long.It was reported that a technical problem of the technician caused the stent to be narrow, and was not related to a quality problem for the medtronic stent.The patient was in a good condition after the procedure.It was reported that none of the adverse events that were mentioned within the article were related directly to medtronic devices.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Please note that this device (endeavor resolute) is not marketed in the united states; however, it is similar to the united states marketed product (resolute integrity).This event is being reported only as a malfunction because of the similar device requirement in 803 which is limited to malfunctions.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDEAVOR RESOLUTE RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8304754
MDR Text Key134993115
Report Number9612164-2019-00416
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P160043:
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/05/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/07/2016
Device Catalogue NumberERES40018X
Device Lot Number0007217148
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/19/2019
Date Device Manufactured07/08/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
-
-